Browse Articles

| Nature Biotechnology (original) (raw)

Article Type

Year

Top ten news stories in 2025

This year’s most popular stories are a testament to biotech ingenuity and a cause for celebration: the gene editing triumph that cured ‘baby KJ’ of a rare genetic disorder in record time; the bispecific molecules that trick HIV out of cells to destroy them; how Brazil is producing its own affordable CAR T cells; and the shift in regulators’ demands for animal testing for certain drug classes.

Editor’s pick: Firefly Bio

Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Firefly Bio seeks to improve on antibody–drug conjugates and proteolysis-targeting chimeras by combining them as degrader–antibody conjugates.

Editor’s pick: Red Queen Therapeutics

Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Red Queen Therapeutics is combating infectious diseases with peptide viral fusion inhibitors.